C
CNTX
Context Therapeutics Inc
0.97
-0.03-3.18%After Hours: 0.9707 +0.0025 +0.26%19:46 09/19 EDT
OPEN/PREV CLOSE1.070/1.000
TODAY RANGE0.9628-1.070
VOL625.10K
MARKET CAP86.85M
52 WEEK RANGE0.4900-2.590
AVG VOL (3M)176.05K
% TURNOVER0.70%
TURNOVER--
P/E (TTM)-2.4296
% RANGE10.72%
EPS(TTM)-0.3985
P/E(FORWARD)-2.8064
P/B1.052
BVPS0.9202
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP85.74M
SHARES OUTSTANDING89.70M
NEXT EARNINGS--
FREE FLOAT88.56M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·2d ago
Context Therapeutics initiated with a Buy at Guggenheim
TipRanks·09/10 15:35
Context Therapeutics management to meet with Maxim
TipRanks·09/02 11:59
Context Therapeutics Granted Nasdaq Extension for Compliance
TipRanks·08/22 03:53
Context Therapeutics Reports Q2 2025 Financial Results
Seeking Alpha·08/07 15:33
Context Therapeutics reports Q2 results
TipRanks·08/07 13:57
Context Therapeutics (CNTX) Gets a Buy from Piper Sandler
TipRanks·08/07 10:05
Context Therapeutics price target lowered to $4 from $5 at H.C. Wainwright
Reuters·08/07 07:56
U.S. RESEARCH ROUNDUP-Applovin, Costco Wholesale, Hubspot
TipRanks·08/07 06:56
William Blair Sticks to Their Buy Rating for Context Therapeutics (CNTX)
Reuters·08/06 20:11
CONTEXT THERAPEUTICS INC. Q2 NET INCOME USD -8.8 MILLION
Same Industry
Name/Symbol
Change%
Price